201. Why does the ability to genetically manipulate organisms create a need for ethical standards and regulation?
ⓐ. Genetic manipulation is biologically incapable of producing any benefit
ⓑ. Every genetically modified organism necessarily causes ecological damage
ⓒ. Biotechnology can provide benefits while also creating risks that require responsible evaluation
ⓓ. Regulation is needed only to control ordinary tissue culture
Correct Answer: Biotechnology can provide benefits while also creating risks that require responsible evaluation
Explanation: Biotechnology can provide major benefits in agriculture, medicine and research, but deliberate manipulation of living organisms can also create consequences that must be evaluated carefully. Ethical and regulatory frameworks are needed since biological interventions may affect patients, other organisms, ecosystems or communities. The need for oversight does not mean that every genetically modified organism is harmful, nor does it deny the benefits of biotechnology. Instead, regulation provides a structured way to assess whether an application is scientifically justified, acceptably safe and responsibly used. The ethical issue arises from the power to modify living systems and the corresponding responsibility to consider both intended advantages and possible harmful outcomes.
202. A genetically modified organism performs well under laboratory conditions, but researchers are uncertain how its release might affect non-target organisms and ecosystem interactions. The principal concern is:
ⓐ. ecological biosafety
ⓑ. C-peptide processing
ⓒ. recombinant insulin assembly
ⓓ. protoplast isolation
Correct Answer: ecological biosafety
Explanation: Ecological biosafety concerns arise when genetically modified organisms may enter environments containing many interacting species and ecological processes. Laboratory performance cannot by itself establish that release will have no unintended effects on non-target organisms, competition, food webs or other ecosystem relationships. The appropriate response is careful risk assessment before environmental introduction. This concern is distinct from ethical questions about patents or ownership, although those issues can also accompany biotechnology. The scenario specifically identifies uncertainty about environmental consequences, making ecological biosafety the relevant category. Responsible biotechnology requires considering not only whether a modification works but also how the modified organism may behave outside controlled conditions. Biological effectiveness does not by itself establish safety for wider use, so regulatory and biosafety assessment remain distinct from proof that the engineered trait works.
203. A proposed genetically modified crop passes tests for the intended trait, but a field study unexpectedly shows a harmful effect on a non-target organism. The most appropriate regulatory interpretation is that:
ⓐ. successful expression of the intended trait makes further assessment unnecessary
ⓑ. the unexpected effect is automatically a patent dispute
ⓒ. the crop should be treated as biologically identical to every conventional variety
ⓓ. the observation raises a biosafety concern that should be evaluated before wider release
Correct Answer: the observation raises a biosafety concern that should be evaluated before wider release
Explanation: Demonstrating that a genetically modified crop expresses its intended trait addresses only one part of safety assessment. An unexpected harmful effect on a non-target organism indicates a possible ecological consequence that must be examined before broader environmental release. This is a biosafety issue as it concerns interaction between the modified organism and other components of the ecosystem. It is not converted into a patent problem merely as biotechnology is involved. The appropriate scientific response is additional evaluation of the observed effect, its reproducibility, severity and ecological significance. Effective biotechnology governance considers both intended performance and unintended biological consequences. Traditional knowledge can have commercial value by directing research toward promising biological resources or applications.
204. In the historical context, the regulatory role attributed to GEAC is most closely associated with:
ⓐ. approving purification of a recombinant therapeutic for commercial production
ⓑ. overseeing routine tissue culture used for clonal plant propagation
ⓒ. assessing GM research validity and safety of proposed public use
ⓓ. deciding patent ownership for products based on traditional biological resources
Correct Answer: assessing GM research validity and safety of proposed public use
Explanation: GEAC has a regulatory role concerned with genetically modified research and the safety of introducing genetically modified organisms for public use. The biological purpose of such oversight is to ensure that applications are evaluated rather than released solely because the intended genetic modification has been achieved. This regulatory role concerns assessment of genetically modified research and proposed public use rather than expanded into unsupported claims about every current legal or administrative detail. GEAC is associated with assessment and oversight of GM applications, not with laboratory techniques such as PCR, plant meristem culture or recombinant insulin production.
205. A research group develops a genetically modified organism and proposes its use outside controlled laboratory conditions. According to the regulatory framework, the most relevant question for GEAC-type oversight is:
ⓐ. whether the organism contains an insulin A chain
ⓑ. whether research validity and public-use safety meet appropriate standards
ⓒ. whether the organism can undergo micropropagation
ⓓ. whether every gene in the organism has been sequenced
Correct Answer: whether research validity and public-use safety meet appropriate standards
Explanation: Regulatory oversight of genetically modified organisms focuses on whether the research is scientifically valid and whether proposed use, especially beyond controlled conditions, can be considered acceptably safe. The regulatory question is broader than confirming that the engineered trait exists. It involves evaluating biological consequences associated with the intended application. This forms part of responsible biotechnology governance. Detailed present-day administrative rules are outside the scope of the regulatory framing, so the important conceptual point is the relationship among genetic modification, public use and safety evaluation. A modified organism should not move automatically from successful laboratory construction to unrestricted public application without appropriate assessment. Responsible biotechnology requires distinguishing technical success from the separate ethical and regulatory questions surrounding wider use.
206. A company obtains legal protection over a biotechnology product or process involving a biological resource. This situation is most directly related to:
ⓐ. an ecological biosafety assessment of environmental release
ⓑ. an intellectual-property or patent matter
ⓒ. a benefit-sharing arrangement with biological-resource providers
ⓓ. an ethical assessment of how living organisms are used
Correct Answer: an intellectual-property or patent matter
Explanation: Patents concern legal protection for inventions, products or processes and can become important when biotechnology makes commercial use of biological resources or associated knowledge. The existence of a patent issue should not automatically be labelled biopiracy. Biopiracy specifically concerns exploitation of biological resources or traditional knowledge without appropriate authorisation, compensation or benefit sharing. A patent may become part of such a dispute, but the two concepts are not synonyms. The scenario here describes legal protection itself without establishing unauthorised exploitation, so the appropriate classification is an intellectual-property or patent issue. Careful distinction between legal protection and unethical resource appropriation is essential for clear biotechnology classification.
207. The Basmati example is used primarily to illustrate a biotechnology-related dispute involving:
ⓐ. patent claims involving traditional Basmati germplasm and derived rice lines
ⓑ. biosafety testing of a GM rice line before environmental release
ⓒ. benefit sharing for authorised commercial use of rice germplasm
ⓓ. ecological effects of pest-resistant rice on non-target organisms
Correct Answer: patent claims involving traditional Basmati germplasm and derived rice lines
Explanation: Basmati is discussed in the context of intellectual property, biological resources and traditional agricultural heritage. The dispute involved patent claims connected with rice lines developed using germplasm related to traditional Indian Basmati varieties. The significance of the example lies in questions about novelty, ownership and commercial rights over biological material that has a long history of cultivation and cultural value. It is not an example of Bt technology, RNA interference or medical recombinant-protein production. The case helps students understand how advances in biotechnology can intersect with patents and longstanding biological resources, creating legal and ethical questions beyond the laboratory itself.
208. Consider the following historical reference facts about Basmati.
I. India is described as having about \(200{,}000\) rice varieties.
II. \(27\) documented Basmati varieties are mentioned.
III. The Basmati patent dispute described is associated with \(1997\).
IV. These figures should be treated as a complete current legal record of all rice-related patents.
Which combination is valid?
ⓐ. I and IV only
ⓑ. II, III and IV only
ⓒ. I, III and IV only
ⓓ. I, II and III only
Correct Answer: I, II and III only
Explanation: The historical data describe about \(200{,}000\) rice varieties in India, mention \(27\) documented Basmati varieties and associate the Basmati patent episode with \(1997\). Statements I, II and III match the supplied historical information. Statement IV goes beyond what those facts establish. Biological-diversity figures and the date of a patent dispute cannot be treated as a complete current legal record of every rice-related patent, since patent claims and legal status can change independently of the historical biological facts. The Basmati case is important for understanding how traditional germplasm, long cultivation and claims of novelty can intersect with intellectual-property questions. Correct interpretation preserves that historical and biological context without turning the figures into permanent contemporary legal statistics. Fair benefit sharing recognises that communities contributing biological resources or traditional knowledge may have legitimate interests in commercial use.
209. Turmeric and neem are mentioned alongside Basmati in discussions of biotechnology-related intellectual property because they illustrate:
ⓐ. examples of transgenic animals producing human proteins
ⓑ. disputes involving traditional biological knowledge or resources and patent claims
ⓒ. crops protected specifically by cryIAc
ⓓ. standard sources of recombinant human insulin
Correct Answer: disputes involving traditional biological knowledge or resources and patent claims
Explanation: Turmeric and neem are used as examples in discussions of attempts to obtain patent protection involving biological uses, products or processes connected with longstanding traditional knowledge. Together with the Basmati example, they illustrate how commercially valuable biological resources and community knowledge can become involved in intellectual-property disputes. The lesson is not that patents themselves are automatically illegitimate. Rather, biotechnology and commercial development can raise questions about novelty, prior knowledge, ownership and fair recognition of the communities or regions from which biological knowledge originates. These examples belong to the ethical and intellectual-property section rather than to genetic engineering mechanisms such as Bt crops or recombinant insulin production.
210. A company collects a medicinal plant used traditionally by an indigenous community, develops a profitable product from that knowledge, and proceeds without obtaining appropriate authorisation or sharing benefits with the community. This situation is best described as:
ⓐ. ordinary patent protection with no ethical dimension for the biological resource
ⓑ. ecological biosafety testing
ⓒ. biopiracy involving unauthorised exploitation without appropriate benefit sharing
ⓓ. gene therapy using a biological resource
Correct Answer: biopiracy involving unauthorised exploitation without appropriate benefit sharing
Explanation: Biopiracy involves the commercial or technological use of biological resources or associated traditional knowledge without proper authorisation, recognition or compensatory benefit sharing. In the scenario, the company gains value from both a biological resource and community knowledge while excluding the source community from permission and benefits. Those features distinguish the case from a neutral patent issue. A patent may be involved in some real disputes, but the defining ethical problem here is unauthorised exploitation and lack of fair compensation. Traditional knowledge can reduce the time and effort needed to identify useful biological applications, so equitable access and benefit sharing become important components of responsible biotechnology. Biological effectiveness, ecological safety, intellectual-property protection and fair use of biological resources are separate issues that can coexist.
211. A research company develops a medicine from a plant traditionally used by a local community. The company obtained the biological material without permission and gives the community no compensation despite commercial success. Which feature most directly establishes a biopiracy concern?
ⓐ. The product is protected by laboratory quality-control procedures
ⓑ. Biological resources are used without proper authorisation or benefit sharing
ⓒ. The medicine is purified before public use
ⓓ. The company performs molecular diagnosis during development
Correct Answer: Biological resources are used without proper authorisation or benefit sharing
Explanation: Biopiracy is not defined simply by commercial use of a biological resource. The central concern is exploitation of biological material or associated traditional knowledge without appropriate permission, recognition, compensation or sharing of benefits with those who supplied or conserved that resource and knowledge. In this scenario, both key elements are present: unauthorised access and absence of benefit sharing despite commercial gain. A legitimate biotechnology product can still involve purification, quality control and intellectual-property protection without automatically becoming an example of biopiracy. The ethical issue arises from the manner in which the resource and knowledge were obtained and used, particularly when the source community receives neither proper authorisation rights nor a fair share of the resulting benefits.
212. Review the statements below concerning biological resources and traditional knowledge.
I. Many developing regions are rich in biodiversity and associated traditional knowledge.
II. Industrially wealthy countries may possess strong technological and financial resources for commercial development.
III. Traditional knowledge may reduce the time and effort needed to identify useful biological applications.
IV. Biodiversity-rich communities automatically receive an equitable share of every commercial benefit.
Which combination is valid?
ⓐ. I and IV only
ⓑ. II, III and IV only
ⓒ. I, III and IV only
ⓓ. I, II and III only
Correct Answer: I, II and III only
Explanation: An imbalance can arise when regions rich in biodiversity and traditional biological knowledge interact with organisations possessing greater financial and technological capacity for commercial development. Traditional knowledge can be scientifically and economically valuable because it may direct researchers toward useful plants, compounds or processes, reducing the time and resources required for discovery. However, the existence of valuable biodiversity or knowledge does not automatically ensure that source communities receive compensation or participate in the benefits. That gap is one reason benefit-sharing rules and legal protection become important. The valid statements describe resource distribution, technological capacity and knowledge value without assuming that commercial fairness occurs automatically. Patent protection concerns legal rights over qualifying inventions, while biopiracy focuses on unfair or unauthorised exploitation of biological resources or traditional knowledge. A valid patent does not by itself resolve questions about permission, compensation or ecological consequences.
213. Researchers learn from a traditional community that a particular plant has long been used for a specific biological purpose. Subsequent investigation reaches a useful commercial application much faster than an unguided search would have. The most appropriate inference is that:
ⓐ. traditional knowledge can reduce time, effort and cost in identifying useful applications
ⓑ. traditional knowledge makes scientific testing unnecessary
ⓒ. community knowledge automatically transfers all ownership rights to a commercial company
ⓓ. a known traditional use can never contribute to biotechnology development
Correct Answer: traditional knowledge can reduce time, effort and cost in identifying useful applications
Explanation: Traditional knowledge can provide an important starting point for biotechnology research by identifying organisms or biological uses that have already been recognised through long experience. This guidance can narrow the search space and reduce the time, labour and financial resources required to discover a potentially useful application. Scientific testing is still required to establish safety, effectiveness and reproducibility, so traditional knowledge does not replace experimental validation. Its commercial value also does not mean that communities automatically surrender rights over their knowledge or resources. The scenario demonstrates why traditional knowledge has economic significance and why responsible commercial development should consider authorisation, recognition and equitable sharing of benefits. The Basmati-type disputes illustrate how claims of novelty can intersect with longstanding farmer-maintained germplasm and traditional biological heritage.
214. Match each biotechnology-governance issue with its most appropriate defining concern.
| Issue | Defining concern |
|---|
| P. Ethical evaluation | I. Whether an activity that affects living organisms is morally and socially acceptable |
| Q. Ecological biosafety | II. Possible unintended environmental consequences of releasing a modified organism |
| R. Patent issue | III. Legal protection over an invention, product or process |
| S. Biopiracy | IV. Unauthorised exploitation of bioresources or traditional knowledge without fair compensation |
ⓐ. P-II, Q-I, R-IV, S-III
ⓑ. P-III, Q-IV, R-I, S-II
ⓒ. P-I, Q-II, R-III, S-IV
ⓓ. P-IV, Q-III, R-II, S-I
Correct Answer: P-I, Q-II, R-III, S-IV
Explanation: These concepts overlap in biotechnology governance but address different questions. Ethical evaluation asks whether an activity affecting living organisms or communities is acceptable in terms of benefit, harm and responsibility. Ecological biosafety concerns biological consequences that may follow environmental release, especially effects on non-target organisms or ecosystems. A patent concerns legal protection for an invention, process or product. Biopiracy is more specific: it involves exploitation of biological resources or traditional knowledge without appropriate authorisation, compensation or benefit sharing. Correctly separating these categories prevents the common error of labelling every biotechnology controversy as either a patent dispute or a biosafety problem when the underlying issue may be fundamentally different. Historical patent examples are useful for understanding resource ownership and fairness, but they should not be converted into unsupported claims about complete current law.
215. A company legally patents a genuinely novel biotechnology process developed entirely from authorised resources and agrees to the required benefit-sharing arrangements with resource providers. Which conclusion is most appropriate?
ⓐ. A biotechnology patent proves that resource use lacked permission or benefit sharing
ⓑ. Patent protection removes the need for a separate biosafety assessment
ⓒ. Patenting can be legitimate when novelty, authorisation and benefit sharing are addressed
ⓓ. Benefit sharing alone proves that every patent claim is biologically novel
Correct Answer: Patenting can be legitimate when novelty, authorisation and benefit sharing are addressed
Explanation: Patent protection and biopiracy are not synonymous. A patent concerns legal rights over an invention, product or process, whereas biopiracy involves unfair or unauthorised exploitation of biological resources or traditional knowledge. In this case, the resources were obtained with authorisation and benefit-sharing obligations were addressed, so the key conditions that would support a biopiracy concern are absent from the information given. The existence of a patent by itself does not justify the label. Ecological biosafety is also a separate issue that would require evidence concerning environmental effects. The scenario illustrates why biotechnology governance requires careful classification of intellectual-property, ethical and resource-access questions rather than assuming that all commercially protected biological innovations represent the same problem.
216. Relate each feature of the Basmati patent example to its biological or historical significance.
| Feature | Significance |
|---|
| P. Longstanding cultivation of Basmati in India | I. Traditional agricultural heritage |
| Q. Use of Indian farmer varieties or germplasm | II. Relevance to questions of derivation and novelty |
| R. Patent claims | III. Intellectual-property rights over claimed products or lines |
| S. Functional equivalents | IV. Possible effects of broad claims on competing equivalent products |
ⓐ. P-I, Q-II, R-III, S-IV
ⓑ. P-II, Q-I, R-IV, S-III
ⓒ. P-III, Q-IV, R-I, S-II
ⓓ. P-IV, Q-III, R-II, S-I
Correct Answer: P-I, Q-II, R-III, S-IV
Explanation: The Basmati example combines biological heritage with intellectual-property questions. Long cultivation establishes the importance of Basmati as a traditional agricultural resource rather than as a newly discovered crop. Use of Indian farmer varieties or related germplasm becomes relevant when evaluating claims of novelty and derivation. Patent claims concern legal rights over specified products or technologies, while sufficiently broad claims may affect the ability of others to sell products considered functionally equivalent. These elements make the case more complex than simple ownership of a plant variety. It illustrates how biotechnology and plant breeding can intersect with traditional resources, commercial rights and questions about whether claimed innovations are genuinely distinct from longstanding biological material. Historical patent examples should be interpreted in their stated context rather than treated as a complete description of current law.
217. Suppose a patent claim on a Basmati-derived product is written so broadly that sellers of functionally equivalent Basmati products could be restricted even when those products arise from longstanding traditional germplasm. The primary concern illustrated by this situation is:
ⓐ. loss of RNAi activity in rice roots
ⓑ. failure of Bt protoxin activation
ⓒ. inability of rice plants to undergo tissue culture
ⓓ. broad patent claims restricting sale or use of equivalent traditional products
Correct Answer: broad patent claims restricting sale or use of equivalent traditional products
Explanation: The scenario concerns the scope of intellectual-property protection rather than the molecular biology of the crop. If a patent claim extends broadly enough to cover products that are functionally equivalent to traditional Basmati forms, it could influence who is permitted to market or commercially exploit those products. This becomes especially significant when the biological material is connected with longstanding farmer varieties and regional agricultural heritage. The issue does not involve Bt toxin, RNA interference or tissue-culture capability. The biological and ethical importance lies in how a legal claim may affect access to, recognition of and commercial use of resources whose genetic background or defining characteristics derive from traditional germplasm. Environmental release can create biosafety questions even when a biotechnology product has useful intended effects.
218. A historical account describes changes made to Indian patent-related provisions in response to concerns about biological resources. Which interpretation is most appropriate when answering a historical biotechnology question?
ⓐ. Treat the paragraph as a complete statement of every current patent law and regulation for biotechnology in all jurisdictions
ⓑ. Use the historical statement in context without treating it as the full current legal position
ⓒ. Ignore the paragraph because patent issues are unrelated to biotechnology
ⓓ. Use the paragraph to conclude that all biological patents are prohibited
Correct Answer: Use the historical statement in context without treating it as the full current legal position
Explanation: Historical discussions of patent policy often describe events and legal responses relevant to the historical period being described. Such material is useful for understanding why concerns about biological resources, traditional knowledge and biopiracy influenced policy. It should not automatically be treated as a complete description of current law, because legal frameworks can change over time and may contain details beyond the scope of the historical statement. The sound interpretation is to preserve the historical meaning while avoiding unsupported claims about the complete present legal position. Patent issues remain relevant to biotechnology, but they mainly illustrate interactions among biological resources, innovation, ownership and fairness. Fair benefit sharing recognises that communities contributing biological resources or traditional knowledge may have legitimate interests in commercial use.
219. Community P authorises access to a medicinal plant and receives an agreed share of profits from a commercial product. Community Q provides neither permission nor consent, yet its traditional knowledge is used commercially and no compensation is provided. Which comparison is best supported?
ⓐ. Q raises greater biopiracy concern because both authorisation and benefit sharing are absent
ⓑ. The P situation is necessarily biopiracy because money is involved
ⓒ. Both situations are identical because a biological resource is commercially used
ⓓ. Neither situation has any relationship to biotechnology ethics
Correct Answer: Q raises greater biopiracy concern because both authorisation and benefit sharing are absent
Explanation: Commercial use of a biological resource is not by itself enough to establish biopiracy. The ethical and legal concern becomes much stronger when biological material or traditional knowledge is used without permission and without fair sharing of benefits. Community P participates through authorisation and receives an agreed return, so the major fairness conditions described are addressed. Community Q experiences the opposite situation: knowledge is appropriated without consent and commercial benefits are retained elsewhere. Comparing the two cases makes clear that responsible biotechnology involves not only scientific development but also how access, consent, compensation and benefit sharing are handled when valuable biological resources or community knowledge contribute to commercial products. Patent, biosafety and biopiracy questions overlap in biotechnology governance but should not be collapsed into one category.
220. A biotechnology company obtains a patent for a genuinely new processing method, but separately it also uses an indigenous community's medicinal knowledge without permission or compensation. Which interpretation is most accurate?
ⓐ. The patent automatically makes every activity of the company ethical under all circumstances
ⓑ. The unauthorised use is only an ecological biosafety issue
ⓒ. The patent and the resource-use issue cancel one another
ⓓ. The patent concerns intellectual property; unauthorised uncompensated use separately concerns biopiracy
Correct Answer: The patent concerns intellectual property; unauthorised uncompensated use separately concerns biopiracy
Explanation: Different biotechnology-governance issues can occur simultaneously and must be evaluated separately. A patent on a genuinely new process concerns intellectual-property protection. That legal protection does not automatically justify unrelated use of biological resources or traditional knowledge. If the company exploits community knowledge without authorisation or compensation, that separate activity fits the defining concern of biopiracy. The presence of one legitimate intellectual-property right cannot erase an independent ethical problem. The scenario demonstrates why patents and biopiracy should not be treated as equivalent concepts. Responsible biotechnology requires attention to both innovation rights and fairness toward those whose biological resources or traditional knowledge contribute to commercial development. Biological effectiveness, ecological safety, intellectual-property protection and fair use of biological resources are separate issues that can coexist.
